ASSEMBLY BIOSCIENCES, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO, CA, 94080
Mailing Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO, CA, 94080
Phone
(833) 409-4583
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
-$6.12M
Net Income
$206.75M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 19, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 9, 2026 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Trades on The Nasdaq Global Select Market under the ticker symbol ASMB.
- Designated as a "Non-accelerated filer" and a "Smaller reporting company," offering regulatory flexibility.
Insider Trading
SELL
2 insiders
4 recent transactions
View Insider Trading Dashboard
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.